Connors Investor Services’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-140,301
Closed -$12.2M 159
2026
Q1
$12.2M Buy
140,301
+274
+0.2% +$26.2K 1.12% 37
2025
Q4
$13.4M Sell
140,027
-997
-0.7% -$96.8K 1.16% 36
2025
Q3
$13.4M Sell
141,024
-3,395
-2% -$312K 1.14% 38
2025
Q2
$12.6M Buy
144,419
+666
+0.5% +$56.5K 1.11% 40
2025
Q1
$12.9M Buy
+143,753
New +$12.9M 1.28% 37
2021
Q4
Sell
-10,681
Closed -$1.34M 168
2021
Q3
$1.34M Hold
10,681
0.14% 102
2021
Q2
$1.33M Hold
10,681
0.14% 102
2021
Q1
$1.26M Buy
+10,681
New +$1.25M 0.14% 104
2016
Q1
Sell
-920
Closed -$234K 191
2015
Q4
$234K Buy
+920
New +$69.3K 0.05% 131

Other funds holding MDT

Connors Investor Services's MDT Position: Q2 2026 in Review

Connors Investor Services sold out of Medtronic (MDT) in Q2 2026, closing a stake of 140,301 shares — an estimated $12.2M sold.

Connors Investor Services first reported a position in MDT in Q4 2015 and held it in 9 quarters. The position peaked at $13.4M in Q4 2025. 2,135 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Connors Investor Services reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • Connors Investor Services sold 140,301 Medtronic shares in Q2 2026, an estimated $12.2M.
  • Connors Investor Services first reported a position in Medtronic in Q4 2015 and held it in 9 quarters.
  • Connors Investor Services's Medtronic position peaked at $13.4M in Q4 2025.
  • 2,135 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Connors Investor Services's 13F filing for Q2 2026, filed 14 Aug 2026.